Skip to Main content Skip to Navigation
Journal articles

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial

Document type :
Journal articles
Complete list of metadata

https://hal.univ-reims.fr/hal-03604991
Contributor : Arnaud Pommier Connect in order to contact the contributor
Submitted on : Thursday, March 10, 2022 - 5:17:48 PM
Last modification on : Friday, March 11, 2022 - 3:12:35 AM

Identifiers

Collections

Citation

Pascal Joly, Maud Maho-Vaillant, Catherine Prost-Squarcioni, Vivien Hebert, Estelle Houivet, et al.. First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial. The Lancet, Elsevier, 2017, 389 (10083), pp.2031-2040. ⟨10.1016/S0140-6736(17)30070-3⟩. ⟨hal-03604991⟩

Share

Metrics

Record views

2